Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197573 · ClinicalTrials.gov registry record · NA
Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT01197573 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 103 participants.
The verdict
NCT01197573, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
We hypothesize that delayed graft function and ITBS events may be related to small blood clots (microthrombi) that collect in the kidneys and liver after cardiac death. Treatment of the DCD organs with a thrombolytic agent prior to implantation may reduce post-transplant morbidity and mortality, and may ultimately result in a greater number of transplantable livers and kidneys.
Interventions
- DRUG rTPA Treatment
- OTHER No TPA Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2010-04 |
| Est. Completion | 2018-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01197573
The ClinicalTrials.gov registry entry for NCT01197573 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which rTPA Treatment is the first listed.
NCT01197573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01197573 about?
NCT01197573 is a clinical study titled "Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy". We hypothesize that delayed graft function and ITBS events may be related to small blood clots (microthrombi) that collect in the kidneys and liver after cardiac death. Treatment of the DCD organs with a thrombolytic agent prior to implantation may reduce post-transplant morbidity and mortality, and...
What is the current status of trial NCT01197573?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2010-04. Estimated completion is 2018-05.
What interventions are being tested in trial NCT01197573?
The interventions under investigation include: rTPA Treatment (DRUG), No TPA Treatment (OTHER).
Who is sponsoring clinical trial NCT01197573?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.